BRIEF-Knight Therapeutics enters into agreement for $200 mln bought deal of common shares
May 11 (Reuters) - Knight Therapeutics
* Bought deal agreement pursuant to which underwriters agreed to purchase 25 million shares of company at $8.00 per common share
* Knight therapeutics enters into agreement for a $200 million bought deal of common shares Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.